Angela Baylina
Family · Homestead, FLNPI 1427665470
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,222, 2.6 times the $477 reported in 2023.
Across 111 payments — averaging $23.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$375
- Merck$263
- Sobi, Inc$230
- Novartis$193
- AstraZeneca$161
- AbbVie$138
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,601100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 16 | $375 |
| Merck | 11 | $263 |
| Sobi, Inc | 9 | $230 |
| Novartis | 10 | $193 |
| AstraZeneca(2 entities) | 8 | $161 |
| AbbVie | 6 | $138 |
| Fennec Pharmaceuticals, Inc. | 1 | $134 |
| Cumberland Pharmaceuticals, Inc. | 5 | $105 |
| Sanofi | 5 | $102 |
| Johnson & Johnson | 4 | $83 |
| Bristol Myers Squibb | 3 | $80 |
| Ipsen Biopharmaceuticals, Inc | 3 | $68 |
| Lilly USA, LLC | 3 | $61 |
| Agios Pharmaceuticals, Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| AVEO Pharmaceuticals, Inc. | 2 | $54 |
| Novocure Inc. | 2 | $51 |
| Amneal Pharmaceuticals LLC | 2 | $45 |
| Dendreon Pharmaceuticals LLC | 2 | $44 |
| Servier Pharmaceuticals LLC | 2 | $39 |
| Menarini Silicon Biosystems, Inc. | 1 | $37 |
| Jazz Pharmaceuticals Inc. | 2 | $35 |
| Gilead | 1 | $30 |
| Puma Biotechnology, Inc. | 2 | $28 |
| Tersera Therapeutics LLC | 1 | $26 |
| ADC Therapeutics America, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| Geron Corporation | 1 | $21 |
| Iovance Biotherapeutics, Inc. | 1 | $20 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Pedmark$134
How this compares
$2,601 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sodium Polystyrene Sulfonate | 45 | $812 |
| Anastrozole | 24 | $264 |
Paid to pharmacies, not to this prescriber.
Other family in Homestead
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.